相关实验视频

Updated: Jun 23, 2025

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Published on: May 11, 2018

2024年更新:关于脊柱肌肉缩的基因治疗的欧洲共识声明

Janbernd Kirschner¹, Günther Bernert², Nina Butoianu³

¹Department of Neuropediatrics and Muscle Disorders, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society

|June 15, 2024

概括

基因治疗 onasemnogene abeparvovec 已经改变了脊髓肌肉缩 (SMA) 护理. 欧洲专家制定了关于它在老年,较重的SMA患者中的使用的共识声明,指导合理的治疗决策.

科学领域:

神经学神经学
遗传学是一个遗传学.
儿科儿科儿科

背景情况:

脊椎肌肉缩 (SMA) 是一种常见的遗传疾病,历史上是婴儿死亡的主要原因.
最近的进展包括改变疾病的治疗方法,特别是基因疗法,显著改善了SMA类型1的结果,特别是当症状前开始时.
基于AAV9的基因疗法Onasemnogene abeparvovec (Zolgensma®) 已被批准用于多达三种SMN2基因拷贝或SMA型1呈现的SMA患者.

研究的目的:

在欧洲专家之间就在SMA治疗中合理使用onasemnogene abeparvovec建立共识.
评估新出现的证据,关于在老年和较重的 SMA 患者中对 onasemnogene abeparvovec 的疗效和安全性.
提供最新的指导,反映基因治疗在治疗脊髓肌肉缩中的演变作用.

主要方法:

一个欧洲神经肌肉专家工作组使用修改后的Delphi方法进行了召开.
专家们评估了最近的临床试验数据和真实世界的证据,对onasemnogene abeparvovec.
该小组根据三年来评估的证据制定了共识陈述.

主要成果:

关于使用onasemnogene abeparvovec.的使用,制定了12个共识声明.
在9个陈述上达成强有力的共识,在剩余的3个陈述上达成共识.
这些发现反映了SMA基因疗法的应用和证据基础的不断扩大.

结论:

达成共识的陈述提供了对SMA患者进行正确选择的指导,以进行纳米诺基因阿贝帕罗维克治疗.
不断发展的证据支持在更广泛的SMA患者中使用基因疗法.
这些专家推的建议旨在优化色素治疗的风险益处概况.

关键词:

腺相关的病毒载体.疾病改变治疗方法.有效性有效性.基因治疗是一种基因疗法.新生儿查新生儿查在另一种类型的虫中,我们发现了虫.安全的安全的安全的安全的安全.脊柱肌肉缩脊柱肌肉缩脊柱肌肉缩生存运动神经元基因生存基因在Zolgensma®®中使用.

更多相关视频

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

Published on: October 3, 2011

Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats

Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats

Published on: May 16, 2025

相关概念视频

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

Satellite Stem Cells and Muscular Dystrophy

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...

What is Genetic Engineering?

What is Genetic Engineering?

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.